null

SMILES CC1C\C(C(=O)O1)=C1/O[C@@H]2CC(=O)N2C1C(=O)OCc1ccccc1

InChI Key InChIKey=DVLLKFBRONEGAN-HBEDQSHMSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 178167   

TargetBeta-lactamase(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 1.07E+3nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent
TargetBeta-lactamase SHV-1(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent
TargetBeta-lactamase TEM(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 0.400nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent
TargetBeta-lactamase(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 301nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent
TargetBeta-lactamase SHV-1(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 0.5nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent
TargetBeta-lactamase TEM(Escherichia coli)
NABRIVA THERAPEUTICS AG

US Patent
LigandPNGBDBM178167(US9120808, Example 46 | US9120808, Example 47)copy SMILEScopy InChI
Affinity DataIC50: 1.70nMpH: 7.0 T: 2°CAssay Description:The inhibitory concentrations (IC50, [uM]) of the beta -lactamase inhibitors against purified TEM-1, SHV-1 and AmpC beta -lactamases are assessed by ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2Q81BT5US Patent